Researchers have identified a new experimental molecule, TOFA, that enables obese subjects to burn fat effectively without the typical side effect of muscle mass loss.
Unlike traditional weight-loss drugs that often require caloric restriction, this molecule stimulates metabolic fat burning while preserving lean tissue, according to recent laboratory studies.
The discovery offers a potential breakthrough for treating obesity-related metabolic disorders, with clinical trials expected to determine the drug's safety and efficacy in human patients.